Trials / Withdrawn
WithdrawnNCT05016921
TcMS to Treat Ventricular Tachycardia
Transcutaneous Magnetic Stimulation of the Stellate Ganglion to Treat Ventricular Tachycardia
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in patients with ventricular tachycardia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TcMS | Transcutaneous magnetic stimulation targeting the stellate ganglion |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2021-08-23
- Last updated
- 2024-04-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05016921. Inclusion in this directory is not an endorsement.